- Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
Rui Liu et al, 2015, European Journal of Pharmacology CrossRef - Structure–Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors
Hirari Yamahana et al, 2021, Chemical and Pharmaceutical Bulletin CrossRef - To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking
Junli Zhang et al, 2023, Frontiers in Pharmacology CrossRef - Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer
Lixia Huang et al, 2022, Current Pharmaceutical Design CrossRef - BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
S. Elizabeth Franks et al, 2016, BMC Research Notes CrossRef - Circ_0014130 Participates in the Proliferation and Apoptosis of Nonsmall Cell Lung Cancer Cells via the miR-142-5p/IGF-1 Axis
Mengjie Wang et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef - Pulmonary Delivery of Docetaxel and Celecoxib by PLGA Porous Microparticles for Their Synergistic Effects Against Lung Cancer
Jaber Emami et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef